1. Cabău G, Crișan TO, Klück V, Popp RA, Joosten LA. Urate‐induced immune programming: Consequences for gouty arthritis and hyperuricemia. Immunological Reviews. 2020;294(1):92-105.
2. Martinon F, Glimcher LH. Gout: new insights into an old disease. The Journal of clinical investigation. 2006;116(8):2073-5.
3. Terkeltaub R. What makes gouty inflammation so variable? BMC medicine. 2017;15(1):1-10.
4. Khanna PP, Shiozawa A, Walker V, Bancroft T, Essoi B, Akhras KS, et al. Health-related quality of life and treatment satisfaction in patients with gout: results from a cross-sectional study in a managed care setting. Patient preference and adherence. 2015;9:971.
5. Juraschek SP, Kovell LC, Miller III ER, Gelber AC. Gout, urate‐lowering therapy, and uric acid levels among adults in the United States. Arthritis care & research. 2015;67(4):588-92.
6. Kuo C-F, Grainge MJ, Zhang W, Doherty M. Global epidemiology of gout: prevalence, incidence and risk factors. Nature reviews rheumatology. 2015;11(11):649.
7. Roddy E, Zhang W, Doherty M. The changing epidemiology of gout. Nature Clinical Practice Rheumatology. 2007;3(8):443-9.
8. Towiwat P, Chhana A, Dalbeth N. The anatomical pathology of gout: a systematic literature review. BMC musculoskeletal disorders. 2019;20(1):140.
9. Wilson L, Saseen JJ. Gouty arthritis: a review of acute management and prevention. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 2016;36(8):906-22.
10. So A, De Meulemeester M, Pikhlak A, Yücel AE, Richard D, Murphy V, et al. Canakinumab for the treatment of acute flares in difficult‐to‐treat gouty arthritis: results of a multicenter, phase II, dose‐ranging study. Arthritis & Rheumatism. 2010;62(10):3064-76.
11. Tausche A, Richter K, Grässler A, Hänsel S, Roch B, Schröder H. Severe gouty arthritis refractory to anti-inflammatory drugs: treatment with anti-tumour necrosis factor α as a new therapeutic option. Annals of the rheumatic diseases. 2004;63(10):1351-2.
12. Neogi T. Gout. New England Journal of Medicine. 2011;364(5):443-52.
13. Xiao N, Chen H, He S-Y, Xue C-X, Sui H, Chen J, et al. Evaluating the efficacy and adverse effects of clearing heat and removing dampness method of traditional Chinese medicine by comparison with western medicine in patients with gout. Evidence-Based Complementary and Alternative Medicine. 2018;2018:1-18.
14. Zhou M, Ze K, Wang Y, Li X, Hua L, Lu Y, et al. Huzhang Tongfeng Granule Improves Monosodium Urate-Induced Inflammation of Gouty Arthritis Rat Model by Downregulation of Cyr61 and Related Cytokines. Evidence-Based Complementary and Alternative Medicine. 2020;2020:1-13.
15. Chi X, Zhang H, Zhang S, Ma K. Chinese herbal medicine for gout: a review of the clinical evidence and pharmacological mechanisms. Chinese Medicine. 2020;15(1):17.
16. Liu Y-F, Huang Y, Wen C-Y-Z, Zhang J-J, Xing G-L, Tu S-H, et al. The effects of modified simiao decoction in the treatment of gouty arthritis: a systematic review and meta-analysis. Evidence-Based Complementary and Alternative Medicine. 2017;2017:6037037.
17. Zhou M, Ze K, Wang Y, Li X, Hua L, Lu Y, et al. Huzhang Tongfeng Granule Improves Monosodium Urate-Induced Inflammation of Gouty Arthritis Rat Model by Downregulation of Cyr61 and Related Cytokines. Evidence-Based Complementary and Alternative Medicine. 2020;2020:9238797.
18. Terkeltaub RA, Furst DE, Bennett K, Kook KA, Crockett R, Davis MW. High versus low dosing of oral colchicine for early acute gout flare: twenty‐four–hour outcome of the first multicenter, randomized, double‐blind, placebo‐controlled, parallel‐group, dose‐comparison colchicine study. Arthritis & Rheumatism. 2010;62(4):1060-8.
19. Yufei L. Effects of Etoricoxib on primary acute severe gouty arthritis. Medical Journal of Chinese people's health. 2018;30(9):21-3.
20. Gutman AB. Uric acid nephrolithiasis. The American journal of medicine. 1968;45(5):756-79.
21. Choi HK, Curhan G. Independent impact of gout on mortality and risk for coronary heart disease. Circulation. 2007;116(8):894-900.
22. Sun M, Vazquez AI, Reynolds RJ, Singh JA, Reeves M, Merriman TR, et al. Untangling the complex relationships between incident gout risk, serum urate, and its comorbidities. Arthritis research & therapy. 2018;20(1):90.
23. Zhu Y, Pandya BJ, Choi HK. Comorbidities of gout and hyperuricemia in the US general population: NHANES 2007-2008. The American journal of medicine. 2012;125(7):679-87. e1.
24. Dalbeth N, Choi HK, Joosten LAB, Khanna PP, Matsuo H, Perez-Ruiz F, et al. Gout. Nat Rev Dis Primers. 2019;5(1):69.
25. Scheepers LE, van Onna M, Stehouwer CD, Singh JA, Arts IC, Boonen A, editors. Medication adherence among patients with gout: a systematic review and meta-analysis. Seminars in Arthritis and Rheumatism; 2018;47(5):689-702.
26. Chua CK, Cheung PP, Santosa A, Lim AY, Teng GG. Burden and management of gout in a multi-ethnic Asian cohort. Rheumatology International. 2019:1-7.
27. Elfishawi MM, Zleik N, Kvrgic Z, Michet CJ, Crowson CS, Matteson EL, et al. The rising incidence of gout and the increasing burden of comorbidities: a population-based study over 20 years. The Journal of rheumatology. 2018;45(4):574-9.
28. Neves C, Shields G, Beard S. A systematic review of the cost burden of gout. Value in Health. 2015;18(7):A656.
29. Spaetgens B, Boonen A. The importance of 'state-of-the-art' cost-of-illness studies. Comment on: The economic burden of gout: A systematic review. Semin Arthritis Rheum. 2016;45(4):e9.
30. Dang W-t, Xie W-g, Zhou J-g. Expression of PYCARD gene transcript variant mRNA in peripheral blood mononuclear cells of primary gout patients with different Chinese medicine syndromes. Chinese journal of integrative medicine. 2018;24(1):24-31.
31. Shao P, Huang X, Zjang F. Research on relationship of syndrome type and parameters of hemorheology and platelet activation in patients with acute gout arthritis of dampness-heat blockage type and stasis-heat accumulate type. Chinese Journal of Integrated Traditional and Western Medicine. 2006;26(11):992-4.
32. Hua L, Zhou M, He Q-h, Zhao H-b, Tang J-y, Li X, et al. Effects of clearing heat and removing dampness and dredging collateral method on expression of NALP3 inflammasome in model of gouty arthritis rats. China Journal of Traditional Chinese Medicine and Pharmacy. 2018;04(33):1591-4.